Novel antibiotic for UTIs passes first clinical trial

A new antibiotic that represents an entirely novel chemical class has passed it first clinical test. The drug, gepotidacin, cured urinary tract infections (UTIs) so well in two large trials that researchers stopped them early. www.science.org/content/article/news-glance-new-antibiotic-covid-19-antarctica-and-venus-mission-deferred? Its manufacturer, GSK, says it plans to seek approval of the drug from the US Food and Drug Administration …

Novel antibiotic for UTIs passes first clinical trial Read More »